In critical COVID-19 patients, a rise in serum IL10 levels occurs subsequently to elevated levels of innate inflammatory molecules IL-1β, IL-6, IL-8, and sTNFR1 during the course of the infection [47]. The gene discussed is CXCL8; the disease is COVID-19.